[1]
Raeisi Estabragh, M.A., Hamidifar, Z. and Pardakhty, A. 2018. Formulation of Rivastigmine Niosomes for Alzheimer Disease. International Pharmacy Acta. 1, 1 (Mar. 2018), 104–104. DOI:https://doi.org/10.22037/ipa.v1i1.19964.